The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

Trials

Volumn 9, Issue , 2008, Pages

  Sandercock, Peter ^a   Lindley, Richard ^b   Wardlaw, Joanna ^a   Dennis, Martin ^a   Lewis, Steff ^a   Venables, Graham ^c   Kobayashi, Adam ^d   Czlonkowska, Anna ^e   Berge, Eivind ^f   Slot, Karsten Bruins ^f   Murray, Veronica ^g   Peeters, Andre ^h   Hankey, Graeme ⁱ   Matz, Karl ^j   Brainin, Michael ^j   Ricci, Stefano ^k   Celani, Maria Grazia ^k   Righetti, Enrico ^k   Cantisani, Teresa ^l   Gubitz, Gord ^m   Phillips, Steve ^m   Arauz, Antonio ⁿ   Prasad, Kameshwar ^o   Correia, Manuel ^p   Lyrer, Phillippe ^q   more..

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g DANDERYD HOSPITAL   (Sweden)

^h CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

ⁱ ROYAL PERTH HOSPITAL   (Australia)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k Ospedale Beato G Villa   (Italy)

^l SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^m DALHOUSIE UNIVERSITY   (Canada)

ⁿ NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^o ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^p HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^q UNIVERSITY HOSPITAL BASEL   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALTEPLASE; ANTIFIBRINOLYTIC AGENT; ANTIHISTAMINIC AGENT; ANTITHROMBOCYTIC AGENT; HEPARIN; STEROID;

ACUTE DISEASE; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER INTERFACE; CONTROLLED STUDY; DEATH; DISEASE DURATION; DRUG APPROVAL; EMBOLISM; FIBRINOLYTIC THERAPY; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HUMAN; IMAGE ANALYSIS; MULTICENTER STUDY; NEUROIMAGING; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTAL MAIL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RECURRENT DISEASE; TELEPHONE;

EID: 47349115423     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-9-37     Document Type: Article

References (48)

1. Murray CJL Lopez AD The Global Burden of Disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 Boston: Harvard University Press 1996.
2. Asplund K Stroke in Europe: Widening gap between East and West Cerebrovascular Diseases 1996, 6:3-6. 10.1159/000107983
3. Chen ZM Sandercock P Pan HC Counsell C Collins R Liu LS Xie JX Warlow C Peto R On behalf of the CAST and IST collaborative groups. Indications for early aspirin use in acute ischemic stroke: A combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the international stroke trial Stroke 2000, 31:1240-9. 10835439
4. The National Institute of Stroke and Neurological Disorders rt-PA Stroke Study Group Tissue Plasminogen Activator for Acute Ischemic Stroke NEJM 1995, 333(24):1581-7. 10.1056/NEJM199512143332401 7477192
5. Hacke W Kaste M Fieschi C Danilo T Lesaffre E von Kummer R Boysen G Bluhmki E Hoxter G Mahagne M Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke JAMA 1995, 274(13):1017-25. 10.1001/jama.274.13.1017 7563451
6. Hacke W Kaste M Fieschi C von Kummer R Davalos A Meier D Larrue V Bluhmki E Davis S Donnan G Schneider D ez-Tejedor E Trouillas P Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) Lancet 1998, 352:1245-51. 10.1016/S0140-6736(98)08020-9 9788453
7. Clark WM Wissoman S Hamandas JH Albers GW Madden KP Hamilton S Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial JAMA 1999, 282:2019-26. 10.1001/ jama.282.21.2019 10591384
8. Albers GW Clark WM Madden KP Hamilton SA The ATLANTIS T-PA Acute Stroke Trial: Results for patients treated within three hours of stroke onset Stroke 2000, 31(1):307.
9. Wardlaw JM del Zoppo G Yamaguchi T Berge E Thrombolysis for acute ischaemic stroke (Cochrane Review) The Cochrane Library Oxford, Update Software 2003. 3
10. Hacke W Donnan G Fieschi C Kaste M von Kummer R Broderick JP Brott T Frankel M Grotta J Haley E Jr Kwiatkowski T Levine S Lewandowski C Lu M Lyden P Marler J Patel S Tilley B Albers G Bluhmki E Wilhelm M Hamilton S Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363:768-74. 2004 March 6 15016487
11. Albers GW Clark WM for the ATLANTIS Study Investigators The ATLANTIS rt-PA (Alteplase) acute stroke trial: Final results Cerebrovascular Diseases 1999, 9(Suppl 1):126. 10087385
12. Donnan G Davis SM When is enough enough? Stroke 2001, 32:2710-2711. 11692042
13. Lindley R Further Randomized Controlled Trials of Tissue Plasminogen Activator Within 3 Hours Are Required Stroke 2001, 32:2708-2709. 11692040
14. Lyden P Further randomized controlled trials of tPA within 3 hours are required-NOT Stroke 2001, 32:2708-2709. 11692040
15. Reed SD Cramer SC Blough DK Meyer K Jarvik JJ Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals Stroke 2001, 32:1832-40. 11486113
16. Johnston S Fung L Gillum L Smith W Brass L Lichtman J Brown A Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic centers. The influence of ethnicity Stroke 2001, 32:1061-8. 10.1161/hs1201.099631 11340210
17. Horowitz SH Thrombolytic therapy in acute stroke: Neurologists, get off your hands! [see comments] Archives of Neurology 1998, 55(2):155-7. 10.1001/archneur.55.2.155 9482356
18. Kaste M Approval of alteplase in Europe: Will it change stroke management? Lancet Neurology 2003, 2:207-208. 10.1016/ S1474-4422(03)00343-0 12849203
19. Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Acute Ischemic Stroke Thrombolytic therapy for acute ischemic stroke Canadian Journal of Emergency Medicine 2001, 3:8-12. 17612434
20. Goyal DG Li J Mann J Schriger DL American Academy of Emergency Physicians position statement on the use of intravenous thrombolytic therapy in the treatment of stroke 2003 http://www.aaem.org/ positionstatements/thrombolytictherapy.php
21. Caplan L Mohr JP Kistler JP Koroshetz W Grotta J Clinical Debate: Should thrombolytic therapy be the first-line treatment for acute ischaemic stroke? New England Journal of Medicine 1997, 337:1309-1313. 10.1056/ NEJM199710303371812 9345084
22. Adams HP Adams RJ Brott T del Zoppo G Furlan AJ Goldstein LB Grubb RL Higashida R Kidwell CS Kwiatkowski T Marler J Hademenos GJ Guidelines for the Early Management of Patients With Ischemic Stroke. A Scientific Statement From the Stroke Council of the American Stroke Association Stroke 2003, 34:1056-1083. 10.1161/01.STR.0000064841.47697.22 12677087
23. Sandercock P Berge E Dennis M Hand P Kwan J Lewis S Neilson AR Lindley R Thomas B Wardlaw JM A systematic review of the effectiveness, cost-effectiveness and barriers to the implementation of thrombolytic and neuroprotective treatment in the NHS Health Technology Assessment 2002, 6(26): 12433319
24. Intercollegiate Working Party for Stroke National Clinical Guidelines for Stroke Update 2002 London, Royal College of Physicians 2002
25. Langhorne P Pollock A What are the components of effective stroke unit care? Age & Ageing 2002, 31(5):365-371. 10.1093/ageing/31.5.365 12242199
26. Leonardi-Bee J Bath PM Phillips S Sandercock P International Stroke Trial Collaborative Group Blood Pressure and Clinical Outcomes in the International Stroke Trial Stroke 2002, 33:1315-1320. 10.1161/ 01.STR.0000014509.11540.66 11988609
27. Tanne D Kasner ES Demchuk AM Koren-Morag N Hanson S Grond M Levine S Multicenter rt-PA Stroke Survey Group Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice. The multicenter rt-PA acute stroke survey Circulation 2002, 105:1679-1685. 10.1161/01.CIR.0000012747.53592.6A 11940547
28. Ciccone A Consent to thrombolysis in acute ischaemic stroke: From trial to practice Lancet Neurology 2003, 2:375-378. 10.1016/ S1474-4422(03)00412-5 12849154
29. Koops L Lindley R Thrombolysis for acute ischaemic stroke: Consumer involvement in the design of new randomised controlled trial British Medical Journal 2002, 325:415-417. 119434 12193356 10.1136/ bmj.325.7361.415
30. Taves DR Minimization: A new method for assigning patients to treatment and control groups Clinical Pharmacology and therapeutics 1974, 15:443-453.
31. Counsell C Dennis M McDowall M Warlow C Predicting outcome after acute and subacute stroke. Development and validation of new prognostic models Stroke 2002, 33:1041-1047. 10.1161/hs0402.105909 11935058
32. Brott T Lu M Kothari R Fagan S Frankel M Grotta J Hypertension and its treatment in the NINDS rt-PA Stroke Trial Stroke 1998, 29:1504-1509. 9707184
33. Blood pressure in Acute Stroke Collaboration Vasoactive drugs for acute stroke Cochrane Library Oxford: Update Software 2003. 2
34. Bath PM Chalmers J Powers W Beilin LJ Davis S Lenfant C Mancia C Neal B Whitworth J International Society of Hypertension Writing Group International Society of Hypertension (ISH): Statement on the management of blood pressure in acute stroke Journal of Hypertension 2003, 21(4):665-672. 10.1097/00004872-200304000-00003 12658006
35. Ludlam C Bennett B Fox KA Lowe G Reid A Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for standards in Haematology Blood Coagul Fibrinolysis 1995, 6(3):273-285. 10.1097/00001721-199505000-00012 7654941
36. von Clauss A Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens Acta Haematol 1957, 17:237- 246. 13434757
37. Hill MD Barber PA Takahashi J Demchuk AM Feasby TE Buchan AM Anaphylactoid reactions and angioedema during alteplase treatment of acute stroke CMAJ 2000, 162:1281-1284. 1232409 10813008
38. Multicentre Acute Stroke Trial Italy (MAST-I) Group Randomised controlled trial of streptokinase, aspirin, & combination of both in treatment of acute ischaemic stroke Lancet 1995, 346:1509-14. 7491044
39. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high-risk patients BMJ 2002, 324:71-86. 64503 11786451 10.1136/ bmj.324.7336.S71
40. Bamford JM Sandercock P Warlow C Slattery J Interobserver Agreement for the Assessment of Handicap in Stroke Patients Stroke 1989, 20:828-828. 2728057
41. Lindley R Waddell F Livingstone M Warlow C Dennis M Sandercock P Can simple questions assess outcome after stroke? Cerebrovasc Dis 1994, 4:314-324. 10.1159/000108501
42. Dorman P Dennis MS Sandercock P Are the modified "simple questions" a valid and reliable measure of health related quality of life after stroke? J Neurol Neurosurg Psychiatry 2000, 69(4):487-93. 1737115 10990509 10.1136/jnnp.69.4.487
43. Dorman P Slattery J Farrell B Dennis M Sandercock P United Kingdom collaborators in the International Stroke Trial A randomised comparison of the EuroQol and Short Form-36 after stroke British Medical Journal 1997, 315:461-461. 2127345 9284664
44. Bamford JM Sandercock P Dennis M Burn J Warlow C Classification and natural history of clinically identifiable subtypes of cerebral infarction Lancet 1991, 337:1521-1526. 10.1016/0140-6736(91)93206-O 1675378
45. Peto R Pike M Armitage P Breslow N Cox D Howard S Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. analysis and examples British Journal of Cancer 1977, 35:1-39. 831755
46. MRC Clinical Trials Series MRC Guidelines for Good Clinical Practice in Clinical Trials London: Medical Research Council 1998.
47. The Safe Implementation of Thrombolysis in Stroke (SITS) website http://www.acutestroke.org accessed on 27 May 2003
48. The Third International Stroke Trial (IST-3) website http://www.ist3.com